Literature DB >> 7181861

Studies on the substrate-binding sites of liver microsomal cytochrome P-448.

C E Phillipson, C Ioannides, M Delaforge, D V Parke.   

Abstract

The interaction of substrates of the microsomal mixed-function oxidases with cytochromes P-450 and P-448 was investigated by using liver microsomes from rats pretreated with phenobarbital or 3-methylcholanthrene, and with purified forms of the cytochromes isolated from rabbit liver. The two forms of the cytochrome have different substrate specificities; cytochrome P-450 has one type 1 substrate-binding site that can accommodate a large variety of substrates, but in contrast cytochrome P-448 may possess two type 1 substrate-binding sites, one of which is different to that of cytochrome P-450 in that it shows a specificity for substrates such as safrole and 9-hydroxy-ellipticine. These findings explain why the two forms of the cytochrome have different substrate specificities and play contrasting roles in the activation and deactivation of xenobiotics.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7181861      PMCID: PMC1153822          DOI: 10.1042/bj2070051

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  19 in total

1.  Purified liver microsomal cytochrome P-450. Separation and characterization of multiple forms.

Authors:  D A Haugen; T A van der Hoeven; M J Coon
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

2.  Inherent specificities of purified cytochromes P-450 and P-448 toward biphenyl hydroxylation and ethoxyresorufin deethylation.

Authors:  M D Burke; R T Mayer
Journal:  Drug Metab Dispos       Date:  1975 Jul-Aug       Impact factor: 3.922

3.  Mechanism of induction of hepatic microsomal drug metabolizing enzymes by a series of barbiturates.

Authors:  C Ioannides; D V Parke
Journal:  J Pharm Pharmacol       Date:  1975-10       Impact factor: 3.765

4.  The stimulation of hydroxylation by carcinogenic and non-carcinogenic compounds.

Authors:  P J Creaven; D V Parke
Journal:  Biochem Pharmacol       Date:  1966-01       Impact factor: 5.858

5.  Spectral studies of drug interaction with hepatic microsomal cytochrome.

Authors:  J B Schenkman; H Remmer; R W Estabrook
Journal:  Mol Pharmacol       Date:  1967-03       Impact factor: 4.436

6.  Ligand interactions with hemoprotein P-450. II. Influence of phenobarbital and methylcholanthrene induction processes on P-450 spectra.

Authors:  C R Jefcoate; J L Gaylor
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

7.  Studies on the nature of the type I and type II spectral changes in liver microsomes.

Authors:  J B Schenkman
Journal:  Biochemistry       Date:  1970-05-12       Impact factor: 3.162

8.  Arene oxides: a new aspect of drug metabolism.

Authors:  D M Jerina; J W Daly
Journal:  Science       Date:  1974-08-16       Impact factor: 47.728

9.  On the problem of possible other forms of cytochrome P450 in liver microsomes.

Authors:  J B Schenkman; H Greim; M Zange; H Remmer
Journal:  Biochim Biophys Acta       Date:  1969-01-07

10.  Induction of drug metabolism. 3. Further information of a new P-450 hemoprotein after treatment of rats with 3-methylcholanthrene.

Authors:  D W Shoeman; M D Chaplin; G J Mannering
Journal:  Mol Pharmacol       Date:  1969-07       Impact factor: 4.436

View more
  2 in total

1.  Determination of cytochrome P-448 activity in biological tissues.

Authors:  C E Phillipson; P M Godden; P Y Lum; C Ioannides; D V Parke
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

Review 2.  Species differences in pharmacokinetics.

Authors:  D V Parke
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.